Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Corneal Diseases × belantamab mafodotin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 51 Recurrence 5 Neoplasms, Plasma Cell 3 Immunoglobulin Light-chain Amyloidosis 3 Amyloidosis 2 Renal Insufficiency 1 Plasmablastic Lymphoma 1 Kidney Failure, Chronic 1 Corneal Diseases 1

Interventions

Dexamethasone 2 pomalidomide 1 nirogacestat 1 daratumumab 1 belantamab mafodotin 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05833737 2025-05-08

Corneal Findings in Patients Treated With Belantamab Mafodotin

Medical University of Vienna

Corneal Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡